Fundraising Fox
Corealis
Laval, CA · Founded 2005 · 50 employees on LinkedIn · 2 known investors
Find your way into Corealis
Sign up to see every warm intro you have to Corealis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Corealis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Corealis Pharma is a contract development and manufacturing organization (CDMO) specializing in oral solid dosage formulation and GMP manufacturing for biotech companies developing complex therapies. The company provides services from early-stage formulation through clinical supply, with integrated R&D and manufacturing infrastructure based in Laval, Canada.
Founders & leadership
DL
David Leroux-PetersenChief Executive OfficerDavid Leroux-Petersen is CEO of Corealis Pharma, a contract development and manufacturing organization specializing in oral solid dosage formulation for biotech companies. He brings over two decades of senior leadership experience across commercial and operational roles in the life sciences sector.
PG
Patrick GosselinVice-President, Pharmaceutical R&D
YM
Yves MougetVice-President, Analytics
PT
Pascal TougasChief Financial OfficerPascal Tougas held finance and operations roles across pharmaceutical, telecommunications, and consulting sectors, with experience in commercial strategy, supply chain management, and business transformation. He is Chief Financial Officer at Corealis Pharma, a contract manufacturing and development organization focused on oral solid dosage formulations for biotech companies.
Investors · 2
La CaissereportedMontréal
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Corealis do?
- Corealis Pharma is a contract development and manufacturing organization (CDMO) specializing in oral solid dosage formulation and GMP manufacturing for biotech companies developing complex therapies. The company provides services from early-stage formulation through clinical supply, with integrated R&D and manufacturing infrastructure based in Laval, Canada.
- Who are Corealis's investors?
- Corealis's investors include ARCHIMED Japan, La Caisse.
- Where is Corealis headquartered?
- Corealis is headquartered in Laval, CA.